The expression of SPARC is dramatically upregulated in the adipose tissue of patients with obesity and in obese rodent models [104,105], and circulating levels of SPARC are also elevated in patients with obesity and T2DM and show a positive correlation with BMI and insulin resistance [106,107]. Here, SPARC is linked to obesity due to melanocortin 4 receptor deficiency.